May 12, 2008. The undersigned members of the Patient and Consumer Coalition write to express our concerns about the April 1 and 2 meetings of the Anti-Infective Drugs Advisory Committee (AIDAC) regarding clinical trial designs for antibiotic treatments for community-acquired pneumonia (CAP).
Read More »On Health Policy
NCHR Testimony at FDA Advisory Panel Meeting on LASIK Devices
April 25, 2008. The FDA’s mission is to ensure that medical products are safe and effective. For LASIK, it is essential that we remember that safe alternatives are less expensive and readily available: glasses and contact lenses.
Read More »NCHR Testimony on FDA Legislation Before the Subcommittee on Energy and Commerce
June 12, 2007. Every American relies on medical devices — whether they use band-aids, contact lenses, or pacemakers. Baby boomers increasingly rely on implanted medical devices, whether hips, heart valves, or wrinkle fillers.
Read More »NCHR Testimony on the Safety of Medical Products
March 9, 2007. The safety of medical products, especially prescription drugs and medical devices, has become an urgent issue for Congress.
Read More »NCHR Joint Statement of Science, Public Health, and Consumer Groups
November 16, 2006. The Enhancing Drug Safety and Innovation Act is an important effort to respond to consumers’ increasing concerns about the inadequacy of current safeguards protecting the public from unreported risks of prescription drugs.
Read More »